Home » Gilead’s Quad Pill Raises Kidney Questions, FDA Says
Gilead’s Quad Pill Raises Kidney Questions, FDA Says
Gilead Sciences’ experimental HIV pill Quad may need additional monitoring because of kidney damage seen in studies, U.S. regulators said.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May